News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Synergistic Cytotoxicity of HDAC and PARP Inhibitors and Decitabine in Pancreatic Cancer Cells: Implications for Novel Therapy

News

June 5, 2024
PRESS RELEASE: On June 3, 2024, a new research paper was published in Oncotarget, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.” continue reading »

Serine Racemase Expression in the Brain During Aging in Male and Female Rats

News

June 5, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 10, entitled, “Serine racemase expression profile in the prefrontal cortex and hippocampal subregions during aging in male and female rats.” continue reading »

Proteomics Uncover Sexual Dimorphism and Immune Changes in Aging Werner Syndrome Mice

Aging

June 3, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 16, Issue 10, entitled, “Integrated liver and serum proteomics uncover sexual dimorphism and alteration of several immune response proteins in an aging Werner syndrome mouse model.” continue reading »

The Importance of Integrated Therapies on Cancer: Silibinin, an Old and New Molecule

News

May 28, 2024
PRESS RELEASE: On May 23, 2024, a new review was published in Oncotarget, entitled, “The importance of integrated therapies on cancer: Silibinin, an old and new molecule.” continue reading »

PH-binding Motifs as a Platform for Drug Design: Lessons From Protease-activated Receptors (PARs)

News

May 24, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs.” continue reading »